Table 1.

Clinical and paraclinical data in 20 patients with newly emerging MOG-EM after vaccination against SARS-CoV-2

Abbreviations: ADEM acute disseminated encephalomyelitis, AI antibody index, AIE autoimmune encephalitis, AQP4 AQP4-IgG-positive neuromyelitis optica spectrum disorders, bl bilateral, BG basal ganglia, BPH benign prostate hyperplasia, BST brainstem, BSTE BST encephalitis, C cervical, C19 coronavirus disease 2019, cbll cerebellar, cMRI cranial MRI, CP cerebellar peduncle, CSO centrum semiovale, CSF cerebrospinal fluid, CTD connective tissue disorders, D dorsal (thoracic), DD differential diagnostics, FamHist family history, FU follow-up, Ger Germany, Gd Gadolinium-enhanced imaging, GFAP glial fibrillary astrocytic protein antibody-associated encephalomyelitis, HIV human immunodeficiency virus, HP hemiparesis, IL6 interleukin-6, IVMP intravenous methylprednisolone, JCV John Cunningham virus, Jap Japan, le left, LETM longitudinally extensive transverse myelitis, MBP myelin basic protein, MCP mid cerebellar peduncle, MMF mycophenolate mofetil, MRI magnetic resonance imaging, MY myelitis, N.d. no data, NB neuroborreliosis, NBe neuro-Behcet, NSa neuro-Sarcoidosis, NTb neuro-tuberculosis, OCB oligoclonal bands, P4 pattern 4 OCB, OS oral steroids, Pat. Patient, PLEX plasma exchange, PP paraparesis, QAlb albumin CSF/serum ratio, ref reference, ri right, SC spinal cord, sMRI spinal MRI, STE supratentorial encephalitis, TCZ tocilizumab, TP total protein, TPa tetraparesis, UK United Kingdom, unil unilateral, v./b inf. viral/bacterial infections, VEP visual evoked potential, WCC white cell count, WM white matter

^§T2/FLAIR if not indicated otherwise; ^&first and follow-up measurements in chronological order; ^#COVID-19 (prior or concomitant); ^%reported as “strongly pos” (no titre given); ^*internal capsule